Pharmacokinetic/Pharmacodynamic Modeling of Corticosterone Suppression and Lymphocytopenia by Methylprednisolone in Rats
- 1 July 2008
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 97 (7) , 2820-2832
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Pharmacokinetic/Pharmacodynamic Modeling of Total Lymphocytes and Selected Subtypes After Oral BudesonideJournal of Pharmacokinetics and Pharmacodynamics, 2006
- Age-related changes in lymphocyte development and functionNature Immunology, 2004
- Dose Equivalency Evaluation of Major Corticosteroids: Pharmacokinetics and Cell Trafficking and Cortisol DynamicsThe Journal of Clinical Pharmacology, 2003
- Role of baseline parameters in determining indirect pharmacodynamic responsesJournal of Pharmaceutical Sciences, 1999
- Diltiazem retards the metabolism of oral prednisone with effects on T‐cell markersPediatric Transplantation, 1999
- Apoptosis of T cells and Macrophages in the Central Nervous System of Intact and Adrenalectomized Lewis Rats During Experimental Allergic EncephalomyelitisJournal of Autoimmunity, 1996
- Glucocorticoid-induced Apoptosis of Lymphoid CellsInternational Archives of Allergy and Immunology, 1994
- Glucocorticoids Activate a Suicide Program in Mature T Lymphocytes:Annals of the New York Academy of Sciences, 1992
- Analysis of methylprednisolone, methylprednisone and corticosterone for assessment of methylprednisolone disposition in the ratJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Pharmacodynamics of Chemotherapeutic Effects: Dose-Time-Response Relationships for Phase-Nonspecific AgentsJournal of Pharmaceutical Sciences, 1971